"Levemir’s action profile makes it perfect for patients who need to make rapid and continual changes," she went on. "An ...

Two other, long-acting "basal" insulins on the market include Sanofi's Lantus and Novo Nordisk's Tresiba. When Levemir is no longer available to U.S. consumers, the senators asked whether the ...

Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin glargine) and biosimilars and Novo Nordisk's newer product Tresiba ...